- ROUNDTABLE: Improving patient outcomes, controlling costs with OTCs
- ROUNDTABLE: Pharmacy’s future in sync with technology
- EXPERT BLOG: Provider status for pharmacists — one way or another
- CVS Caremark to stop selling tobacco in all store locations
- USPLabs agrees to recall and destroy dietary supplement following FDA actions
ATLANTA — An interactive health-and-wellness screening kiosk for consumers has received regulatory approval from the Food and Drug Administration.
SoloHealth said its SoloHealth Station, which currently is installed in select U.S. test markets and retail locations, has received FDA clearance. The SoloHealth Station provides health screenings for vision, blood pressure, weight and body mass index, a symptom checker, as well as an overall health assessment free of charge. SoloHealth also helps connect consumers to local professionals through their databases, helping people enter the most appropriate and accurate point in the healthcare system. The kiosk recently was honored with Intel's IT healthcare award (the "Intel Innovation Award") that recognizes leading-edge technology and exceptional innovation for healthcare delivery and processes.
"We hold accuracy, reliability, and safety standards at the highest level and are pleased to have met and exceeded regulatory standards with the testing trials we have conducted nationwide," SoloHealth COO Stephen Kendig said. "With the FDA clearance, we can now aggressively begin our nationwide rollout of the SoloHealth Station, providing consumers free access to their health data in convenient retail locations across the U.S. We believe our SoloHealth Station will help educate and empower millions of Americans to take charge of their own health and should ultimately lead to a healthier, more efficient, and more financially sound nationwide healthcare system."
SoloHealth said it expects roll out additional kiosks to retail pharmacy locations nationwide by end of the year and is slated to announce partnerships with retailers and strategic alliances within the next one to two months.